Evoke Pharma Inc (EVOK) — Strategic Asset Allocation Index
Evoke Pharma Inc (EVOK) has a Strategic Asset Allocation Index of 9.8% as of June 2023. Strategic assets (PP&E of $52.84K plus long-term investments of $-) total $52.84K, measured against net assets of $538.37K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Evoke Pharma Inc Strategic Asset Allocation Index (2013–2022)
This chart shows how Evoke Pharma Inc's Strategic Asset Allocation Index has evolved across 8 annual periods from 2013 to 2022. As of June 2023, the index stands at 9.8%, representing strategic assets of $52.84K against net assets of $538.37K USD. Explore EVOK cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Evoke Pharma Inc (2013–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Evoke Pharma Inc from 2013 to 2022, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Evoke Pharma Inc worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 3.2% | $129.07K | $129.07K | $- | $4.08 Million | ▲ +2.8 pp |
| 2021 | 0.3% | $12.43K | $12.43K | $- | $3.56 Million | ▼ -2.8 pp |
| 2019 | 3.2% | $138.54K | $138.54K | $- | $4.38 Million | ▲ +3.2 pp |
| 2017 | 0.0% | $0.00 | $0.00 | $- | $2.17 Million | ▲ +0.0 pp |
| 2016 | 0.0% | $0.00 | $0.00 | $- | $3.79 Million | ▲ +0.0 pp |
| 2015 | 0.0% | $0.00 | $0.00 | $- | $3.46 Million | ▲ +0.0 pp |
| 2014 | 0.0% | $0.00 | $0.00 | $- | $9.19 Million | ▲ +0.0 pp |
| 2013 | 0.0% | $0.00 | $0.00 | $- | $21.18 Million | — |